2m 2m 2m 2m 2m 2m 2m
KALVISTA PHARMAC (KALV)
NASDAQ
$26.95+$0.006 (+0.02%)
Price as of Jun 03, 2026 7:12 PM EDT- $1.4BMarket Cap
- 101.80%1-Year Change
- BiotechnologyIndustry
KALVISTA PHARMAC (KALV)
$26.95+$0.006 (+0.02%)
KALV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $26.94 | ||
Change | $0.00 (0.00%) | ||
Open | $26.95 | ||
High | $26.95 | ||
Low | $26.93 | ||
Previous Close | $26.94 | ||
Volume | 1,512,055 | ||
30-Day Average Volume | 3,543,139 | ||
1-Week Change | 0.48% | ||
1-Month Change | 1.09% | ||
1-Year Change | 101.80% | ||
3-Year Change | 169.40% | ||
5-Year Change | 1.13% | ||
Fundamentals | |||
Shares Outstanding | 53.2M | ||
Total Assets | $328.9M | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $39.2M | ||
Net Income | -$23.5M | ||
Free Cash Flow | -$14.6M | ||
EBIT | -$22.2M | ||
EBITDA | -$21.8M | ||
Net Working Capital | $253.4M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -62 | ||
Enterprise Value/Revenue | 35 | ||
P/B | -73 | ||
P/E | -62 | ||
PEG | 0 | ||
Price/Free Cash Flow | -98 | ||
Price/Operating Cash Flow | -99 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue